Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02025803
Title A Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With Capecitabine in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications

colorectal cancer

Advanced Solid Tumor

breast cancer

Therapies

Capecitabine + TAS-114

Age Groups: adult
Covered Countries USA


No variant requirements are available.